Global Anticoccidial Drugs Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Anticoccidial Drugs Market Research Report 2024
Coccidiosis is an infection of the intestinal tract of animals which is caused by coccidia protozoa. The disease is characterized by invasion of the intestinal wall by the protozoa. Coccidia undergo several stages of growth and multiplication. Coccidia damages mucosal and submucosal tissues of the intestinal tract. The disease is especially prevalent when animals and birds are grouped together in significant numbers by their infected feces and tissues. Coccidia infect a wide variety of animals, such as poultry species, cattle, sheep and pigs and can cause devastating lose in meat production.
According to Mr Accuracy reports’s new survey, global Anticoccidial Drugs market is projected to reach US$ 1403 million in 2034, increasing from US$ 1181.5 million in 2024, with the CAGR of 2.0% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anticoccidial Drugs market research.
Growing demand for meat proteins are increasing usage of anticoccidial drugs and are the driving force for global anticoccidial drugs market. Besides, less stringent regulations and increased expenditure on companion animals are also assistant in growth of global anticoccidial drugs market. Further, the trend of owning companion animals is causative to the growing usage of anticoccidials in developing regions.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anticoccidial Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Merial
Novartis Animal Healthcare
Ceva Santé Animale
Boehringer Ingelheim
Virbac
Zoetis
Biopredic
Intas
Dosch Pharma
Jurox
Segment by Type
Antibiotic Anticoccidials
Ionophore Anticoccidials
Chemical Derivative Anticoccidials
Poultry
Swine
Fish
Cattle
Companion Animals
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Anticoccidial Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Anticoccidial Drugs market is projected to reach US$ 1403 million in 2034, increasing from US$ 1181.5 million in 2024, with the CAGR of 2.0% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anticoccidial Drugs market research.
Growing demand for meat proteins are increasing usage of anticoccidial drugs and are the driving force for global anticoccidial drugs market. Besides, less stringent regulations and increased expenditure on companion animals are also assistant in growth of global anticoccidial drugs market. Further, the trend of owning companion animals is causative to the growing usage of anticoccidials in developing regions.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anticoccidial Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merial
Novartis Animal Healthcare
Ceva Santé Animale
Boehringer Ingelheim
Virbac
Zoetis
Biopredic
Intas
Dosch Pharma
Jurox
Segment by Type
Antibiotic Anticoccidials
Ionophore Anticoccidials
Chemical Derivative Anticoccidials
Segment by Application
Poultry
Swine
Fish
Cattle
Companion Animals
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Anticoccidial Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source